[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cullinan Therapeutics Inc (CGEM)

Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cullinan Therapeutics Inc ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 USA

www.cullinanoncology.com Employees: 109 P: 617-410-4650

Sector:

Medical

Description:

Cullinan Therapeutics Inc. is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. The company's product pipeline consists CLN-978. Cullinan Therapeutics Inc., formerly known as Cullinan Oncology Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 894,112
Enterprise Value, $K 805,782
Shares Outstanding, K 61,451
Float, K 57,051
% Float 92.84%
Short Interest, K 8,115
Short Float 13.21%
Days to Cover 10.56
Short Volume Ratio 0.63
% of Insider Shareholders 7.16%
% of Institutional Shareholders 86.31%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -219,880 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -50,710 K
EBIT, $ -241,660 K
EBITDA, $ -241,350 K

Growth:

1-Year Return 95.36%
3-Year Return 49.08%
5-Year Return -47.40%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 38.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.77 on 03/10/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -3.35
EPS Growth vs. Prev Qtr 2.60%
EPS Growth vs. Prev Year -1.35%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CGEM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.04%
Return-on-Assets % -45.64%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.13
Book Value/Share 6.92
Interest Coverage -3.05
60-Month Beta -0.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.